Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

UNCOVERED: Sndl - Caught on Camera

SNDL Stock Layoffs: What to Know About the Latest SNDL Job Cuts

SNDL disclosed layoffs alongside its fiscal Q3 earnings. But does that warrant buying SNDL stock today? Let’s find out!

Barchart · Oct 27

Wall Street Is Betting That SNDL Stock Can More Than Double in the Next Year. Should You Buy Shares Here?

SNDL stock rallies on reports President Donald Trump will soon reclassify marijuana as Schedule III drug. Analysts expect SNDL shares to more than double from here in 2026.

Barchart · Dec 17, 2025

4 Cannabis Stocks Log Momentum Gains Even As Congress Re-Criminalizes Some THC Products In Spending Bill

Four cannabis stocks are demonstrating significant technical momentum, seemingly undeterred by new regulatory headwinds from Washington.

Benzinga · Nov 14, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

Tilray Brands, SNDL, Innoviz Technologies, Pony AI And Other Big Stocks Moving Higher On Monday

U.S. stocks were mixed, with the Nasdaq Composite gaining more than 100 points on Monday.

Benzinga · Sep 29, 2025

8 Stocks Less Than $5 That Have The Potential to Make You A Millionaire

Are you dreaming of turning a small investment into a life-changing fortune? The stock market is full of surprises; sometimes, the biggest winners hide in plain sight, right among the stocks under $5. These affordable stocks, often called “penny stocks,” can be risky, but they also offer the kind of…

The Free Financial Advisor · May 25, 2025

Pharma Buy, Hold, or Sell: 4 Stocks Worth Considering

The pharmaceutical industry is anticipated to thrive as demand grows and technology advances. However, given the macroeconomic uncertainties, let us analyze leading pharma stocks Zoetis (ZTS), Verano Holding (VRNOF), Canopy Growth (CGC) and SNDL (SNDL) to identify whether they are a Buy, Hold, or Sell. Read on.

StockNews.com · Jan 30, 2024

SNDL Inc. (SNDL) vs. GSK plc (GSK): Analyzing the Better Long-Term Pharma Investment

Amid the burgeoning technological innovation and its seamless integration, investors' interest seems to gravitate toward the pharmaceutical industry. Keeping this in mind, which of the stocks, SNDL Inc. (SNDL) and GSK plc (GSK), could be a better long-term investment? Let's find out.

StockNews.com · Nov 22, 2023

Read news from The Economist, FT, and more,
with one subscription

What Lies Ahead for SNDL Inc. (SNDL) and Canopy Growth (CGC)?

The cannabis industry is undergoing a turbulent time due to legalization troubles and its struggles to realize gains. Amid this, would it be wise to invest in SNDL Inc. (SNDL) and Canopy Growth (CGC) now? Keep reading….

StockNews.com · Oct 13, 2023

Which of These 3 Pharma Stocks Are a Buy?

The pharma industry is expected to experience substantial growth in the coming years with expanding global medical needs. So, which of these pharma stocks, Ipsen (IPSEY), Collegium Pharmaceutical (COLL), and SNDL (SNDL), are a buy now? Keep reading.

StockNews.com · Aug 16, 2023

Is It Finally Time to Buy Shares of SNDL Inc. (SNDL)?

Despite aggressive expansionary strategies, Canadian cannabis producer SNDL Inc. (SNDL) exhibits weak profitability. Therefore, should investors buy the stock now? Let’s look at its financial metrics to gauge its prospects….

StockNews.com · Aug 7, 2023

2 Must-Have Pharma Stocks to Buy in August, 1 to Sell

The pharmaceutical industry is poised to thrive amid increasing global healthcare demand. Hence, two quality pharma stocks, Johnson & Johnson (JNJ) and Novartis AG (NVS), could be solid portfolio additions. However, avoiding fundamentally weak stock SNDL Inc. (SNDL) could be a wise choice. Read more.

StockNews.com · Aug 3, 2023

Buy, Hold or Sell in July: Canopy Growth (CGC) and SNDL Inc. (SNDL)

Although the cannabis industry shows long-term growth potential, its near-term performance is hampered by intense regulations and limited financing. So, let's analyze whether you should Buy, Hold or Sell cannabis stocks SNDL (SNDL) and Canopy Growth (CGC).

StockNews.com · Jul 4, 2023

Is SNDL Inc. (SNDL) a Buy or Sell this Summer?

Canadian cannabis producer SNDL (SNDL) witnessed solid revenue growth over the past few years. However, its bottom line is in the red. Also, considering the heightened regulatory pressures, is the stock worth buying now? Keep reading.

StockNews.com · Jun 12, 2023

Which Pharma Stock is a Pick for June: Pfizer (PFE) or SNDL Inc. (SNDL)?

The pharmaceutical industry is known for its resilience during challenging economic times, primarily due to the inelastic demand for essential medicines. As the specter of a potential recession hangs over the market, let us analyze two leading players in the sector, Pfizer (PFE) and SNDL (SNDL), to find the better…

StockNews.com · Jun 7, 2023

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com · Jun 1, 2023

Is SNDL Inc. (SNDL) Overbought?

Canadian cannabis company SNDL Inc. (SNDL) enjoys major investor attention and belongs to the Robinhood top 100 stocks list. However, should investors consider buying this stock now? Read more….

StockNews.com · May 22, 2023

Johnson & Johnson (JNJ) and SNDL Inc. (SNDL) -- Buy or Sell?

Investing in healthcare stocks could help hedge against economic downturns. Thus, Johnson & Johnson (JNJ) could be worth buying. However, I think SNDL (SNDL) is best avoided considering its weak fundamentals. Read on.

Barchart · Apr 28, 2023

Here’s Why Cannabis Stocks Suddenly Look Interesting

Over the past year, cannabis stocks suffered significantly but a reintroduction of a banking reform bill may spark legitimacy in the controversial sector.

StockNews.com · Mar 23, 2023

2 Cannabis Stocks to Think Twice About Before Buying

The cannabis industry has been facing several economic and regulatory challenges. Demand has also slowed amid a glut in supply. With the Fed unlikely to stop interest rate hikes, the economy could enter a recession this year. Amid this backdrop, it could be wise to avoid fundamentally weak cannabis stocks…

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com · Mar 22, 2023

3 Stocks You Should Sell Now

After the blow of several bank failures in recent weeks, investors are now eyeing the Fed’s policy decision, scheduled to release today. Given fears of an economic downturn, eliminating fundamentally weak stocks Lucid Group (LCID), Robinhood Markets (HOOD), and SNDL Inc. (SNDL) from your watchlist could be wise before the…

StockNews.com · Mar 20, 2023

3 Stocks to Remove From Your Watchlist

The recent bank failures have stoked fears of financial instability, and the Fed is widely expected to opt for a small or no rate hike this week. With fears of an economic downturn on the horizon, it could be wise for investors to remove fundamentally weak stocks Plug Power (PLUG),…

StockNews.com · Mar 17, 2023

If You Own This Drug Manufacturer Stock, It’s Time to Sell

Canadian cannabis producer SNDL (SNDL) has made several acquisitions to support its growth. Although the company witnessed solid revenue growth in its last reported quarter, its bottom line was in the red. The company’s return to profitability remains uncertain. Moreover, given the regulatory challenges, I think this fundamentally weak stock…

StockNews.com · Mar 14, 2023

2 Risky Cannabis Stocks to Avoid Right Now

Following remarkable growth in recent years, the cannabis industry faced various legal and economic challenges, including overproduction amid high inflation, high taxes, and increased material costs impacting overall sales in 2022. The industry will likely remain under pressure amid concerns over rising inflation and a potential recession. Hence, it could…

StockNews.com · Mar 6, 2023

3 Cannabis Stocks to Avoid Like the Plague in March 2023

The cannabis industry faced several challenges last year, including overproduction amid high inflation weighing on overall demand. With growing concerns over rising inflation and a looming recession, the industry is expected to remain under immense pressure this year. So, it could be wise to avoid fundamentally weak cannabis stocks Tilray…

StockNews.com · Mar 2, 2023

2 Pharma Stocks to Buy Right Now and 1 You Might Want to Consider Selling

The pharmaceutical industry is evolving with personalized medicines and the rapid adoption of RPM technology, which should boost growth. Moreover, with a recession lurking, fundamentally strong pharma stocks AstraZeneca (AZN) and Bristol-Myers Squibb (BMY) might be ideal buys. However, SNDL (SNDL) might be best avoided. Keep reading to know why.

StockNews.com · Feb 20, 2023

1 Medical Stock to Buy in February and 1 to Avoid Like the Plague

The medical industry is expected to grow due to increasing healthcare requirements and federal support. Moreover, given the inelastic demand for healthcare products and services, fundamentally strong medical stock Nature's Sunshine Products (NATR) could be an ideal buy this month. However, SNDL (SNDL) might be best avoided, considering its weak…

1 2

Coverage From

People

Mangeet Kaur BounsMangeet

595 stories

Steve Reitmeister

508 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

US Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.